FBRX – Forte Biosciences Inc
Forte Biosciences, Inc.FBRX
$9.61Name : Forte Biosciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $117,374,616.00
EPSttm : -9.51
Forte Biosciences, Inc.
$9.61
3.71%$0.37Float Short %
1.16
Margin Of Safety %
Put/Call OI Ratio
1.2
EPS Next Q Diff
0.33
EPS Last/This Y
7.79
EPS This/Next Y
1.18
Price
9.61
Target Price
45.67
Analyst Recom
1
Performance Q
34.16
Relative Volume
0.38
Beta
2.91
Ticker: FBRX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | FBRX | 13.66 | N/A | N/A | 0 |
| 2025-07-07 | FBRX | 12.75 | N/A | N/A | 0 |
| 2025-07-08 | FBRX | 12.48 | N/A | N/A | 0 |
| 2025-07-09 | FBRX | 12.48 | N/A | N/A | 0 |
| 2025-07-10 | FBRX | 11.51 | N/A | N/A | 0 |
| 2025-07-11 | FBRX | 10.52 | N/A | N/A | 0 |
| 2025-07-14 | FBRX | 9.78 | N/A | N/A | 0 |
| 2025-07-15 | FBRX | 9.53 | N/A | N/A | 0 |
| 2025-07-16 | FBRX | 9.71 | N/A | N/A | 0 |
| 2025-07-17 | FBRX | 10.02 | N/A | N/A | 0 |
| 2025-07-18 | FBRX | 10.24 | N/A | N/A | 0 |
| 2025-07-21 | FBRX | 10.5 | N/A | N/A | 0 |
| 2025-07-22 | FBRX | 10.57 | N/A | N/A | 0 |
| 2025-07-23 | FBRX | 10.75 | N/A | N/A | 0 |
| 2025-07-24 | FBRX | 10.69 | N/A | N/A | 0 |
| 2025-07-25 | FBRX | 11.6 | N/A | N/A | 0 |
| 2025-07-28 | FBRX | 11.87 | 0.00 | 1.20 | 0 |
| 2025-07-29 | FBRX | 10.62 | 0.00 | 1.20 | 0 |
| 2025-07-30 | FBRX | 10.25 | 0.00 | 1.20 | 0 |
| 2025-07-31 | FBRX | 10.09 | 0.00 | 1.20 | 0 |
| 2025-08-01 | FBRX | 9.62 | 1.20 | 999.99 | 11 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | FBRX | 13.66 | 83.6 | - | -4.38 |
| 2025-07-07 | FBRX | 12.74 | 83.6 | - | -4.38 |
| 2025-07-08 | FBRX | 12.48 | 83.6 | - | -4.38 |
| 2025-07-09 | FBRX | 12.48 | 83.6 | - | -4.38 |
| 2025-07-10 | FBRX | 11.45 | 83.6 | - | -4.38 |
| 2025-07-11 | FBRX | 10.55 | 83.6 | - | -4.38 |
| 2025-07-14 | FBRX | 9.84 | 83.6 | - | -4.38 |
| 2025-07-15 | FBRX | 9.45 | 83.6 | - | -4.38 |
| 2025-07-16 | FBRX | 9.68 | 83.6 | - | -4.38 |
| 2025-07-17 | FBRX | 9.96 | 83.6 | - | -4.38 |
| 2025-07-18 | FBRX | 10.19 | 83.6 | - | -4.38 |
| 2025-07-21 | FBRX | 10.36 | 83.6 | - | -4.38 |
| 2025-07-22 | FBRX | 10.57 | 83.6 | - | -4.38 |
| 2025-07-23 | FBRX | 10.64 | 83.6 | - | -4.38 |
| 2025-07-24 | FBRX | 10.75 | 83.6 | - | -4.38 |
| 2025-07-25 | FBRX | 11.60 | 83.6 | - | -4.38 |
| 2025-07-28 | FBRX | 11.89 | 83.6 | - | -4.38 |
| 2025-07-29 | FBRX | 10.66 | 83.6 | - | -4.38 |
| 2025-07-30 | FBRX | 10.19 | 83.6 | - | -4.38 |
| 2025-07-31 | FBRX | 9.98 | 83.6 | - | -4.38 |
| 2025-08-01 | FBRX | 9.61 | 83.6 | - | -4.38 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | FBRX | 0.00 | -8.99 | 1.68 |
| 2025-07-07 | FBRX | 0.00 | -8.76 | 1.68 |
| 2025-07-08 | FBRX | 0.00 | -8.76 | 1.68 |
| 2025-07-09 | FBRX | 0.00 | -8.76 | 1.68 |
| 2025-07-10 | FBRX | 0.00 | -8.76 | 1.68 |
| 2025-07-11 | FBRX | 0.00 | -8.76 | 1.38 |
| 2025-07-14 | FBRX | 0.00 | 32.41 | 1.24 |
| 2025-07-15 | FBRX | 0.00 | 32.41 | 1.24 |
| 2025-07-16 | FBRX | 0.00 | 32.41 | 1.24 |
| 2025-07-17 | FBRX | 0.00 | 32.41 | 1.24 |
| 2025-07-18 | FBRX | 0.00 | 32.41 | 1.24 |
| 2025-07-21 | FBRX | 0.00 | 32.41 | 1.24 |
| 2025-07-22 | FBRX | 0.00 | 32.41 | 1.24 |
| 2025-07-23 | FBRX | 0.00 | 32.41 | 1.24 |
| 2025-07-24 | FBRX | 0.00 | 32.41 | 1.24 |
| 2025-07-25 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-07-28 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-07-29 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-07-30 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-07-31 | FBRX | 0.00 | 32.41 | 1.16 |
| 2025-08-01 | FBRX | 0.00 | 32.41 | 1.16 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.37
Avg. EPS Est. Current Quarter
-1.18
Avg. EPS Est. Next Quarter
-1.04
Insider Transactions
Institutional Transactions
32.41
Beta
2.91
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
6
Growth Score
19
Sentiment Score
6
Actual DrawDown %
99.3
Max Drawdown 5-Year %
-99.7
Target Price
45.67
P/E
Forward P/E
PEG
P/S
P/B
1.65
P/Free Cash Flow
EPS
-13.81
Average EPS Est. Cur. Y
-4.38
EPS Next Y. (Est.)
-3.2
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.38
Return on Equity vs Sector %
-137.5
Return on Equity vs Industry %
-118.8
EPS 1 7Days Diff
0.3
EPS 1 30Days Diff
0.55
EBIT Estimation
Forte Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 14
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading